» Articles » PMID: 7286032

Pharmacokinetics of Amiodarone After Intravenous and Oral Administration

Overview
Specialty Pharmacology
Date 1981 Mar 1
PMID 7286032
Citations 30
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of a non-animal toolbox informed by adverse outcome pathways for human inhalation safety.

de Avila R, Muller I, Barlow H, Middleton A, Theiventhran M, Basili D Front Toxicol. 2025; 7:1426132.

PMID: 40061084 PMC: 11885506. DOI: 10.3389/ftox.2025.1426132.


A physiologically-based pharmacokinetic modeling approach for dosing amiodarone in children on ECMO.

Yellepeddi V, Hunt J, Green D, McKnite A, Whelan A, Watt K CPT Pharmacometrics Syst Pharmacol. 2024; 13(9):1542-1553.

PMID: 39033462 PMC: 11533098. DOI: 10.1002/psp4.13199.


Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay.

Jeong K, Chang J, Park S, Kim J, Jeon S, Kim D Antiviral Res. 2022; 209:105473.

PMID: 36435212 PMC: 9682871. DOI: 10.1016/j.antiviral.2022.105473.


- Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned.

Algharably E, Di Consiglio E, Testai E, Pistollato F, Mielke H, Gundert-Remy U Front Toxicol. 2022; 4:885843.

PMID: 35924078 PMC: 9340473. DOI: 10.3389/ftox.2022.885843.


Low-dose Amiodarone Is Safe: A Systematic Review and Meta-analysis.

Chokesuwattanaskul R, Shah N, Chokesuwattanaskul S, Liu Z, Thakur R J Innov Card Rhythm Manag. 2020; 11(4):4054-4061.

PMID: 32368381 PMC: 7192149. DOI: 10.19102/icrm.2020.110403.


References
1.
ROSENBAUM M, Chiale P, Ryba D, Elizari M . Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol. 1974; 34(2):215-23. DOI: 10.1016/0002-9149(74)90200-8. View

2.
Grand A . [Myxedema caused by amiodarone; a further case]. Coeur Med Interne. 1975; 14(1):163-7. View

3.
Geerts M . Amiodarone pigmentation. An electron microscopic study. Arch Belg Dermatol Syphiligr. 1971; 27(4):339-51. View

4.
JONCKHEER M, Blockx P, KAIVERS R, Wyffels G . Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol. 1973; 28(2):192-200. View

5.
Charlier R, BAUDINE A, CHAILLET F, DELTOUR G . [Studies of the benzofuran series. XXV. Hemodynamic effects of amiodarone in the dog]. Acta Cardiol. 1967; 22(4):323-49. View